当前位置:首页 - 行情中心 - 华熙生物(688363) - 财务分析 - 资产负债表

华熙生物

(688363)

  

流通市值:199.17亿  总市值:199.17亿
流通股本:4.82亿   总股本:4.82亿

资产负债表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
流动资产:
  货币资金1,003,660,402.23994,984,838.22728,478,034.7776,595,920.95
  交易性金融资产60,964,738.0633,291,542.26--
  应收票据及应收账款598,000,775.94564,465,173.49550,181,135.98557,874,220.84
        应收账款598,000,775.94564,465,173.49550,181,135.98557,874,220.84
  应收款项融资10,017,662.642,318,9981,246,72010,056,966.69
  预付款项128,630,457.692,480,960.68118,596,618.59104,744,781.49
  其他应收款合计46,767,656.4642,264,918.6639,012,553.8540,642,033.15
  存货929,577,340.77980,621,587.191,123,437,322.831,168,267,450.85
  一年内到期的非流动资产31,925,00031,715,000--
  其他流动资产51,984,680.8842,849,920.2838,983,474.760,599,998.76
  流动资产合计2,861,528,714.582,784,992,938.782,599,935,860.652,718,781,372.73
非流动资产:
  长期股权投资426,156,469.22418,353,990.6417,747,256.17421,359,294.77
  其他权益工具投资85,052,086.8358,620,808.9652,969,761.5952,966,653.23
  其他非流动金融资产92,525,007.3793,160,070.4188,321,394.4988,586,448.61
  固定资产3,497,348,730.163,537,504,718.713,470,874,301.873,534,492,420.7
  在建工程446,203,902.18438,519,020.24497,996,369.15443,009,785.21
  使用权资产96,464,233.1278,531,987.4966,388,058.4791,485,348.9
  无形资产512,220,165.21517,620,302.65516,334,361.98504,449,730.76
  商誉171,022,471.9177,624,403.47181,614,534.71182,240,499.77
  长期待摊费用149,689,063.85155,123,070.57107,780,817.85106,647,638.12
  递延所得税资产336,140,744.56335,557,908.46346,815,968.79339,845,541.33
  其他非流动资产75,654,400.8596,898,104.22122,616,220.5288,941,053.73
  非流动资产合计5,888,477,275.255,907,514,385.785,869,459,045.595,854,024,415.13
  资产总计8,750,005,989.838,692,507,324.568,469,394,906.248,572,805,787.86
流动负债:
  短期借款160,082,456.0692,887,687.7350,033,500-
  应付票据及应付账款602,067,242.84668,094,083.52621,558,687.39674,333,336.09
  其中:应付票据51,000,00011,550,0004,000,0002,466,000
        应付账款551,067,242.84656,544,083.52617,558,687.39671,867,336.09
  合同负债70,439,734.957,771,749.7466,870,124.2882,449,589.92
  应付职工薪酬145,231,069.32140,811,910.27100,453,817.6297,692,540.49
  应交税费70,826,908.7576,790,250.254,991,205.7352,630,694.89
  其他应付款合计36,200,209.0835,053,603.6252,270,877.74105,863,913.7
        应付股利1,918,012.111,918,012.111,918,012.1154,537,909.55
  一年内到期的非流动负债100,625,690.19114,317,184.6588,465,922.02105,676,934.9
  其他流动负债25,872,249.24,280,076.535,668,511.157,754,357.37
  流动负债合计1,211,345,560.341,190,006,546.261,040,312,645.931,126,401,367.36
非流动负债:
  长期借款68,740,096.9594,663,333.3458,754,784.0182,108,649.98
  租赁负债64,870,650.2839,507,878.6734,982,110.6445,915,225.59
  递延收益242,296,708.06248,941,995.77239,836,042.61249,005,504.17
  递延所得税负债3,129,061.764,240,551.135,410,771.464,358,138.22
  非流动负债合计379,036,517.05387,353,758.91338,983,708.72381,387,517.96
  负债合计1,590,382,077.391,577,360,305.171,379,296,354.651,507,788,885.32
所有者权益(或股东权益):
  实收资本(或股本)481,678,242481,678,242481,678,242481,678,242
  资本公积3,849,649,216.673,849,649,216.673,855,787,683.233,855,946,874.14
  减:库存股219,947,377.83219,947,377.83219,947,377.83219,947,377.83
  其他综合收益14,124,546.9134,652,359.2142,279,915.9246,820,136.83
  盈余公积253,808,683.26253,808,683.26253,808,683.26253,808,683.26
  未分配利润2,750,467,595.482,685,812,855.882,646,134,649.652,614,606,195.3
  归属于母公司股东权益合计7,129,780,906.497,085,653,979.197,059,741,796.237,032,912,753.7
  少数股东权益29,843,005.9529,493,040.230,356,755.3632,104,148.84
  股东权益合计7,159,623,912.447,115,147,019.397,090,098,551.597,065,016,902.54
  负债和股东权益合计8,750,005,989.838,692,507,324.568,469,394,906.248,572,805,787.86
公告日期2026-04-302026-04-232025-10-292025-08-27
审计意见(境内)标准无保留意见
TOP↑